Production (Stage)
Inhibrx Biosciences, Inc.
INBX
$14.39
$0.473.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.89% | -22.28% | -13.46% | -- | -- |
| Total Receivables | -49.05% | -62.73% | -18.75% | 356.25% | -60.93% |
| Inventory | -5.46% | -34.60% | -38.05% | -40.63% | -16.00% |
| Prepaid Expenses | -36.19% | -17.79% | -25.08% | 70.35% | -29.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 74.62% | -34.89% | -11.62% | 31.52% | 44.70% |
| Total Current Assets | 39.27% | -22.68% | -14.30% | 1,606.67% | -95.20% |
|
|
|||||
| Total Current Assets | 39.27% | -22.68% | -14.30% | 1,606.67% | -95.20% |
| Net Property, Plant & Equipment | -8.04% | 61.09% | -12.60% | 1.72% | 0.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.41% | 1.77% | -0.49% | 47.08% | 44.94% |
| Total Assets | 34.23% | -18.78% | -13.88% | 815.66% | -90.83% |
|
|
|||||
| Total Accounts Payable | 18.06% | 9.09% | -22.28% | 0.13% | -48.06% |
| Total Accrued Expenses | -0.65% | -15.26% | 48.09% | 2.90% | -8.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 23.70% | -13.08% | -15.48% | 2.55% | 2.62% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.14% | -7.63% | 12.91% | 1.62% | -31.75% |
|
|
|||||
| Total Current Liabilities | 7.14% | -7.63% | 12.91% | 1.62% | -31.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.51% | -- | -- | -- | -49.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 214.09% | 7.00% | 12.91% | 0.15% | -85.25% |
|
|
|||||
| Common Stock & APIC | 1.74% | 1.26% | 1.27% | 2,270.56% | -101.64% |
| Retained Earnings | -40.81% | -82.15% | -304.55% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -29.30% | -25.15% | -18.64% | 2,136.82% | -124.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.30% | -25.15% | -18.64% | 2,136.82% | -124.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.30% | -25.15% | -18.64% | 2,136.82% | -124.76% |
|
|
|||||